Agilent Technologies investment thesis focuses on expanding its leadership in life sciences and diagnostics by continually investing in cuttingedge technologies and innovation. The company targets sectors with high growth potential, including pharmaceuticals, biotechnology, and applied chemical markets. Agilent aims to drive value creation by developing solutions that address critical challenges in health, safety, and environmental sustainability, supporting longterm growth and market expansion.